In conclusion, our results show a sex-specific modulation of the association between cognition and systemic inflammation, as measured by serum CRP levels, and suggest the existence of a subgroup of female patients who could benefit from anti-inflammatory treatments to ameliorate cognitive impairment. Here, CRP is linked to Cognitive impairment.